Advertisement

Topics

Archytas Ventures, LLC Company Profile

06:52 EDT 15th August 2018 | BioPortfolio

Archytas Ventures is a private, opportunistic investment holding company with offices in New York and Los Angeles. Archytas Ventures provides strategic capital solutions to the emerging and undercapitalized cannabis industry. For more information, visit www.ArchytasVentures.com.


News Articles [310 Associated News Articles listed on BioPortfolio]

Archytas Ventures’ Portfolio Company, Xtraction Services, Raises Oversubscribed $2.8M Series B Round to Accelerate Growth

Xtraction Services (“XS”), an Archytas Ventures portfolio company that specializes in CO2 supercritical extraction equipment, lab devices, and best-in-industry service, today ...

League raises fresh capital to grow employee health benefits platform

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Ventu...

RubiconMD wraps up $13.8M Series B to connect PCPs and specialists

The round, which was led by HLM Ventures and Optum Ventures, included participation from Centene Corporation, Alma Mundi Ventures and others.

Eko raises $5mm in Series A round

Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic Partners, Dreamlt Ventures, 1812 Ventures, and founder.org.

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) raised $15.7mm in an oversubscribed Series A financing led by Hatteras Venture ...

Eko raises $5M Series A to add staff, support clinical studies for digital stethoscope

ARTIS Ventures led the Series A round. Other investors that took part included Strategic Partners, Dreamlt Ventures, 1812 Ventures, and FOUNDER.org.

AI firm Atomwise secures $45mm Series A round

Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group. Returning backers Y Comb...

Brain-machine interface start-up Paradromics brings in $7mm in seed funding

Paradromics Inc. (implantable brain-machine interface (BMI) technology) brought in $7mm in a seed financing round co-led by Arkitekt Ventures (adds a board member) and Synergy Ventures. It-Farm, Dolby...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.

American hospitals are increasingly turning to service outsourcing to reduce costs, including laboratory services. Studies of this practice have largely focused on nonacademic medical centers. In cont...

Tiny Conveyance: Micro- and Nanorobots Prepare to Advance Medicine.

In the science-fiction classic Fantastic Voyage [1], a shrink-ray zaps a submarine and the crew within it, and the resulting microscopic vehicle ventures inside a human body to destroy a blood clot an...

With tree nut sensitization, take the current when it serves, or lose our ventures.

Tree nut allergy affects approximately 1.4-2.3%, depending on the study methodology, patient age, and region in which the study was conducted.1,2 Tree nut allergy can be severe, and tends to persist t...

"Yes, we know!" (Over)confidence in general knowledge among Austrian entrepreneurs.

Overconfidence has been reported to be a common bias among entrepreneurs and might be one cause of the high failure rates observed for new ventures. In this study, we investigate the overconfidence bi...

Detecting opinion spams through supervised boosting approach.

Product reviews are the individual's opinions, judgement or belief about a certain product or service provided by certain companies. Such reviews serve as guides for these companies to plan and monito...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent Graft

The ARCHYTAS Registry is a long-term, global, multicenter, non-randomized, prospective, registry designed to collect "on-label" data in real world clinical settings on patients undergoing ...

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [545 Associated Companies listed on BioPortfolio]

Archytas Ventures, LLC

Archytas Ventures is a private, opportunistic investment holding company with offices in New York and Los Angeles. Archytas Ventures provides strategic capital solutions to the em...

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Extraordinary Ventures, Inc.

Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...

Jina Ventures

Founded in 2003, Jina Ventures is a New York-based private equity and M&A advisory firm. Over the past 6 years, Jina Ventures has grown into a full service private equity practice, with both principal...

Rizk Ventures

Rizk Ventures is a privately-held investment firm based in New York, founded by Thomas A. Rizk and Linda Rizk. Rizk Ventures focuses on investment activities in the areas of Ventu...

More Information about "Archytas Ventures, LLC" on BioPortfolio

We have published hundreds of Archytas Ventures, LLC news stories on BioPortfolio along with dozens of Archytas Ventures, LLC Clinical Trials and PubMed Articles about Archytas Ventures, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Archytas Ventures, LLC Companies in our database. You can also find out about relevant Archytas Ventures, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record